Metabolomic Technologies Inc - Product Pipeline Analysis, 2018 Update

Metabolomic Technologies Inc - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME341300PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastrointestinal diseases in their early stages. MTI's products are used in the treatment of breast cancer, prostate cancer, celiac disease, ulcerative colitis, Crohn's disease, IBD, lactose intolerance, acid reflux and gastric ulcers. The company provides metabolomics analysis for various applications including sample preparation, data collection, statistical analysis, and interpretation. It also conducts research and development programs to identify metabolomic fingerprints in urine samples. MTI is headquartered in Edmonton, Alberta, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Metabolomic Technologies Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Metabolomic Technologies Inc Company Overview 4

Metabolomic Technologies Inc Company Snapshot 4

Metabolomic Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Metabolomic Technologies Inc-Pipeline Analysis Overview 6

Metabolomic Technologies Inc-Key Facts 6

Metabolomic Technologies Inc-Major Products and Services 7

Metabolomic Technologies Inc Pipeline Products by Development Stage 8

Metabolomic Technologies Inc Pipeline Products Overview 10

BreastDx 10

BreastDx Product Overview 10

CeliacDx 11

CeliacDx Product Overview 11

ColitisDx 12

ColitisDx Product Overview 12

CrohnsDx 13

CrohnsDx Product Overview 13

IBDDx 14

IBDDx Product Overview 14

LactoseDx 15

LactoseDx Product Overview 15

ProstateDx 16

ProstateDx Product Overview 16

RefluxDx 17

RefluxDx Product Overview 17

UlcerDx 18

UlcerDx Product Overview 18

Metabolomic Technologies Inc-Key Competitors 19

Metabolomic Technologies Inc-Key Employees 20

Metabolomic Technologies Inc-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Metabolomic Technologies Inc, Recent Developments 22

May 31, 2018: PolypDx Offered After American Cancer Society Lowers Recommended Age for Colorectal Cancer Screening 22

Jun 27, 2016: ADL Launches Revolutionary Urine-Based Diagnostic Test To Detect Precursor To Deadly Colorectal Cancer 22

Sep 01, 2014: MTI travels to China for clinical trial and new business opportunities 23

Appendix 24

Methodology 24

About GlobalData 27

Contact Us 27

Disclaimer 27

List of Figures

Metabolomic Technologies Inc Pipeline Products by Equipment Type 5

Metabolomic Technologies Inc Pipeline Products by Development Stage 8

List of Tables

Metabolomic Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Metabolomic Technologies Inc Pipeline Products by Equipment Type 5

Metabolomic Technologies Inc Pipeline Products by Indication 5

Metabolomic Technologies Inc, Key Facts 6

Metabolomic Technologies Inc, Major Products and Services 7

Metabolomic Technologies Inc Number of Pipeline Products by Development Stage 8

Metabolomic Technologies Inc Pipeline Products Summary by Development Stage 9

BreastDx-Product Status 10

BreastDx-Product Description 10

CeliacDx-Product Status 11

CeliacDx-Product Description 11

ColitisDx-Product Status 12

ColitisDx-Product Description 12

CrohnsDx-Product Status 13

CrohnsDx-Product Description 13

IBDDx-Product Status 14

IBDDx-Product Description 14

LactoseDx-Product Status 15

LactoseDx-Product Description 15

ProstateDx-Product Status 16

ProstateDx-Product Description 16

RefluxDx-Product Status 17

RefluxDx-Product Description 17

UlcerDx-Product Status 18

UlcerDx-Product Description 18

Metabolomic Technologies Inc, Key Employees 20

Glossary 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

BioMark Technologies Inc

Norgen Biotek Corp

Clinotech Diagnostics & Pharmaceuticals Inc

Metabolomic Technologies Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51675
Site License
USD 1500 INR 103350
Corporate User License
USD 2250 INR 155025



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]